1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow TG4010: new trials by email Literature Review of TG4010 trials Research Report on TG4010
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer TG4010, placebo - Non-Small-Cell Lung Carcinoma | Phase 2 / Phase 3 | Terminated | Transgene | 222 | 2012-04-01 | 2017-01-05 |
Carcinoma, Non-Small-Cell Lung (1)
Transgene (1)
Belgium (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)